OR WAIT 15 SECS
FUJIFILM Diosynth Biotechnologies opens Cambridge, MA center to promote collaboration with biotech companies.
In advance of the 2018 BIO convention in Boston (June 5–7), FUJIFILM Diosynth Biotechnologies announced on May 31, 2018 the opening of its Cambridge (MA) Collaboration Center, featuring an atrium with event and meeting spaces designed to facilitate biotech partnership and education.
“With partnering as a key theme of the BIO convention, Fujifilm is thrilled to reveal its new Cambridge Collaboration Center, a space that will encourage partnership between biopharma leaders in Boston and beyond,” said Steve Bagshaw, chief executive officer of FUJIFILM Diosynth Biotechnologies in a press statement. “As a center for biotech innovation, at BIO 2018 Fujifilm will showcase its gene-therapy manufacturing and development solutions, which are designed to meet the needs of our partners to quickly and reliably support the delivery of advanced therapies to patients.”
Bagshaw will moderate a session at the BIO event, Delivering on the Promise of Gene Therapy, that will explore the way gene therapies are transforming patients’ lives, the challenges and opportunities in gene therapy scientific discovery, and new approaches in delivering new types of medicines to patients.